Clinical Trial

Staged Kidney Transplantation During Combined Heart/Kidney Transplantation

Recruiting
View on ClinicalTrials.gov →
Summary
The primary purpose of this study is to evaluate the safety and efficacy of ex vivo machine perfusion with staged implantation of kidney allografts during combined heart/kidney transplantation.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-03-10; most recent amendment 2026-07-22.
Status change: Not Yet Recruiting → Recruiting 2025-05-29
Trial Details
NCT Number NCT06877169
Lead Sponsor Cedars-Sinai Medical Center
Conditions Heart Failure, Chronic Kidney Disease, End-stage Kidney Disease
Enrollment 20 participants
Start Date 2025-04-07
Primary Completion 2027-02-28 (estimated)
Study Completion 2035-02-28 (estimated)
Updated on ClinicalTrials.gov 2026-07-24